Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Googles data centers grow so fast it has to build its own networks

    Jun 18, 2015, 00:00 AM by Michael Croft
    Computerworld | Google has been building its own software-defined data-center networks for 10 years because traditional gear can't handle the scale of its warehouse-sized computers.
    Full story
  • ARIDHIA’S DATA SCIENCE PLATFORM USED IN SIX MILLION EURO EU PROJECT

    Jun 17, 2015, 00:00 AM by Michael Croft
    EDINBURGH, UNITED KINGDOM - Jun 17, 2015 - ARIDHIA'S DATA SCIENCE PLATFORM USED IN SIX MILLION EURO EU PROJECT Aridhia's data science platform AnalytiXagility has been chosen to underpin a €6 million oral healthcare innovation project funded by the EU's Horizon 2020 programme and the funding win demonstrates huge confidence in Aridhia's data analytics capability
    Full story
  • Genedata and IntelliCyt Forge Alliance to Transform Cell-based Screening in Drug Discovery

    Jun 17, 2015, 00:00 AM by Michael Croft
    ALBUQUERQUE, NM, UNITED STATES - Jun 17, 2015 - Genedata and IntelliCyt today announced an alliance that brings together the market-leading strengths of each company to transform screening of suspension cells
    Full story
  • Tute Genomics Announces Investment Round from Intermountain, Tencent

    Jun 16, 2015, 15:00 PM by Michael Croft
    Bio-IT World News Brief | Tute Genomics today announced the closing of its Series A1 round of venture capital funding. The company raised over $3.9 million from a strategic group of investors, including Intermountain Healthcare, Healthbox, and China-based Tencent.
    Full story
  • Whole Genome Assembly with Nanopore Data

    Jun 16, 2015, 08:50 AM by Michael Croft
    Bio-IT World News Brief | Nature Methods has published a paper by researchers at the University of Birmingham and University of Toronto, demonstrating a complete de novo assembly of an E. coli genome using only data from an Oxford Nanopore MinION Sequencer.
    Full story
  • FDA taps PatientsLikeMe to test the waters of social media adverse event reporting

    Jun 16, 2015, 00:00 AM by Michael Croft
    mobihealthnews | PatientsLikeMe has announced a research partnership with the FDA: The agency will assess the platform's feasibility as a way to generate adverse event reports, which the FDA uses to regulate drugs after their release into the market.
    Full story
  • Matthew Trunnell Joins Fred Hutchinson Cancer Research Center

    Jun 16, 2015, 00:00 AM by Michael Croft
    Xconomy | Trunnell leaves the Broad to serve as the chief information officer as the biomedical institution moves into an era of deep genomic sequencing.
    Full story
  • Agena Bioscience European Distributors Expand to KAWA.SKA and BioGen-Analytica

    Jun 11, 2015, 00:00 AM by Michael Croft
    SAN DIEGO, CA, UNITED STATES - Jun 11, 2015 - Agena Bioscience today expanded its European distributors through new relationships with KAWA.SKA in Poland and BioGen-Analytica in Russia
    Full story
  • Outpouring of Commentary on CRISPR Germline Editing

    Jun 10, 2015, 13:30 PM by Michael Croft
    Bio-IT World News Brief | A supplementary document to a recent Nature Biotechnology article on the use of CRISPR-Cas9 genome editing in the human germline offers complete Q&A's with over 20 experts in the field, taking on pressing questions about how and whether this technology can be regulated.
    Full story
  • ClinGen and Lessons for the Precision Medicine Initiative

    Jun 10, 2015, 10:00 AM by Michael Croft
    Bio-IT World | Heidi Rehm has been involved in ClinGen since its inception and recently published a report on the project in the New England Journal of Medicine. Rehm’s experience with ClinGen will make hers an important voice as the infrastructure needs for a Precision Medicine Initiative are better defined.
    Full story
  • DIGITAL SCIENCE ANNOUNCES NEW MANAGING DIRECTOR

    Jun 9, 2015, 00:00 AM by Michael Croft
    BOSTON, MA, UNITED STATES - Jun 9, 2015 - London, UK & Boston, USA. June 9th 2015:  Digital Science announced today the appointment of Daniel Hook, currently Director of Research Metrics at Digital Science, as its new Managing Director
    Full story
  • BGI's Industrial Scale Sequencer Challenges Illumina's HiSeq Line

    Jun 8, 2015, 17:00 PM by Michael Croft
    Bio-IT World | BGI, the Shenzhen-based global genomics corporation, has revealed its first DNA sequencing instrument for worldwide markets, Revolocity: an ultra-high-throughput, fully automated system based on technology developed by BGI's subsidiary Complete Genomics.
    Full story
  • Kickstarter Launched for Social Reader

    Jun 8, 2015, 16:00 PM by Michael Croft
    Bio-IT World | David Mittelman and his colleagues at N of Everyone today launch a Kickstarter campaign to fund Reader, a mobile and social reading platform to promote conversation and collaboration within science. 
    Full story
  • A New Regenerative Drug Molecule For Pancreas Was Introduced

    Jun 8, 2015, 00:00 AM by Michael Croft
    NEW YORK, NY - Jun 8, 2015 - BOC Sciences-recently a new synthetic molecule was introduced by an authoritative research center in America
    Full story
  • The Human Virome's Permanent Mark

    Jun 5, 2015, 13:50 PM by Michael Croft
    Bio-IT World | The human body is host to an astonishing array of viruses, but efforts to study this secretive population have hit technological limitations. At Brigham & Women's Hospital in Boston, a new blood test is letting researchers look at patients' whole histories of viral infection, using their antibodies as a permanent record.
    Full story
  • Vicon Celebrates Accelerated Growth in Life Sciences with the Addition of New Customers

    Jun 5, 2015, 00:00 AM by Michael Croft
    OXFORD, UNITED KINGDOM - Jun 5, 2015 - Motion capture technology specialist Vicon has announced growing momentum in the life sciences sector with several recent customer wins
    Full story
  • Rho Chairman and Co-Founder Ronald W. Helms Inducted as a Fellow Of the Society for Clinical Trials

    Jun 5, 2015, 00:00 AM by Michael Croft
    CHAPEL HILL, NC - Jun 5, 2015 - For Immediate Release Rho Chairman and Co-Founder Ronald W. Helms Inducted as a FellowOf the Society for Clinical Trials Chapel Hill, NC  ̶  June 4, 2015  ̶  Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, recently announced that its Chairman and Co-founder Ronald W
    Full story
  • Frontier Pharma: Parkinsons Disease - Identifying and Commercializing First-in-Class Innovation

    Jun 4, 2015, 00:00 AM by Michael Croft
    ALBANY, UNITED STATES - Jun 4, 2015 - Market Research Reports Search Engine (MRRSE) has announced the addition of the ' Frontier Pharma: Parkinsons Disease - Identifying and Commercializing First-in-Class Innovation' report by Market Research Reports Search Engine to its rapidly growing market research report database
    Full story
  • Celgene Bluebird Streamline CAR-T Partnership To Fight Myeloma

    Jun 4, 2015, 00:00 AM by Michael Croft
    Xconomy | The immuno-oncology field is moving fast these days, but the tough-to-treat blood cancer multiple myeloma has not been one of its early targets.
    Full story
  • Business The billion-dollar biotech

    Jun 4, 2015, 00:00 AM by Michael Croft
    Nature News & Comment | Moderna Therapeutics has big ambitions and a bankroll to match. How a fledgling start-up became one of the most highly valued private drug firms ever.
    Full story
  • «
  • 361
  • 362
  • 363
  • 364
  • 365
  • 366
  • 367
  • 368
  • 369 (current)
  • 370
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy